Liang Qiao

Sep 6, 2024 | mdpi.com | Liang Qiao |Tao Shen |Lei Hua |Hongna Li

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Dec 6, 2023 | frontiersin.org | Liang Qiao

This research aims to establish a platform for evaluating the clinical effectiveness and safety of minimally invasive therapies for liver, gallbladder, and gastrointestinal tumors. Additionally, it seeks to explore advanced non-invasive diagnostic methods for predicting tumor prognosis and unravel the molecular mechanisms associated with tumor recurrence in these areas.

Oct 26, 2023 | frontiersin.org | Liang Qiao

1 IntroductionGastrointestinal cancers are becoming increasingly serious health concerns, with rising incidence rates due to shifts in dietary habits, environmental pollution, and other risk factors (1, 2). The current primary therapeutic approaches for gastrointestinal cancer include surgery, chemotherapy, radiotherapy, and more recently, immunotherapy (3, 4).

Oct 24, 2023 | frontiersin.org | Liang Qiao |Zheng Yuan

IntroductionGastric cancer prevalence has shown a marked decline during the last few decades (1), but this cancer is still associated with a high mortality rate and causes many deaths (2). There are marked geographical differences in the prevalence of gastric cancer, with the highest being in East Asia (3).

Aug 28, 2023 | frontiersin.org | Liang Qiao

Peritoneal metastasis is the main cause of death in gastric cancer patients. Despite radical gastric cancer surgery, peritoneal metastasis occurs in about 50% of gastric cancer patients and the overall survival is less than 6 months (1, 2).